Illustrative physician-owned aesthetic practice sale to a dermatology group

This teaching composite is not a real client deal. A physician-owned aesthetic practice with $2.8 million revenue is evaluated by a dermatology group. The example separates $391,000 normalized EBITDA from buyer synergies, a $1.88 million assumed price, future clinical pay, and the seller’s immediate cash after debt, costs, escrow, and a hypothetical reserve.

What does the aesthetic practice look like?

Assume a physician owns an aesthetic practice generating $2.8 million annual earned revenue. The physician provides treatment, clinical leadership, and local relationships. A dermatology group is interested in the services and geography but must verify the business independently rather than presume that shared professional interests establish integration fit.

The illustration assumes the proposed structure can be supported by qualified healthcare counsel. Physician status does not settle every entity, contract, staffing, service, records, or control question. The financial analysis therefore remains separate from the legal path to continued care and the buyer’s operating plan.

How are reported earnings adjusted?

Assume net income is $362,000 after $22,000 interest, $43,000 depreciation, and $9,000 amortization. Reported EBITDA is $436,000. Add $18,000 documented personal expense and $31,000 nonrecurring legal expense under the teaching assumptions.

The accounts include $174,000 current owner compensation cost. The replacement clinical role is budgeted at $268,000, an incremental $94,000. Normalized EBITDA is $436,000 + $18,000 + $31,000 − $94,000 = $391,000.

The calculation retains the original compensation cost and subtracts only the additional replacement amount. Removing all owner cost and omitting replacement would describe a different earnings measure, while subtracting the full replacement amount again would double count part of the labor expense.

What should the dermatology group verify about fit?

Review provider production, service mix, patient return patterns, schedules, staff compensation, products, devices, lease, memberships, and administrative systems. Identify which strengths depend on the selling physician and which belong to a repeatable team. A professional relationship is not evidence that every patient will transfer.

Compare clinical and administrative responsibilities separately. The California Medical Board’s practice guidance illustrates jurisdiction-specific professional-control and departure questions. Healthcare counsel should evaluate the actual entities, state, services, providers, and proposed decision rights rather than treating physician ownership as a complete legal answer.

Ask whether the group has management and qualified coverage available now. Existing resources can create benefits but can also be fully occupied. The investment case should identify the cost and responsibility of integration rather than assume the target can rely on unlimited support from the purchaser’s other practices.

How does the assumed valuation range work?

Use invented factors of 4.3 and 5.1 against $391,000 normalized EBITDA to show arithmetic sensitivity. The resulting range is $1,681,300 to $1,994,100. These inputs are not observed dermatology or med spa transaction multiples and do not establish a recommended price.

Assume the negotiated consideration is $1.88 million. That amount must still be evaluated against funding, provider continuity, legal feasibility, obligations, and terms. It is not justified merely by falling within a hypothetical range or being offered by a strategic buyer.

Keep standalone earnings visible when the buyer discusses its own savings. A larger purchaser may see value from systems, purchasing, or management, but must pay for implementation and assess the chance of achieving it. The seller should not rewrite historical financials as though those benefits were already earned.

What are the buyer’s integration assumptions?

Assume the group projects $60,000 recurring administrative savings but needs $45,000 additional annual integration and clinical-support cost. Its projected recurring result is $391,000 + $60,000 − $45,000 = $406,000 on the same defined basis.

Now assume $96,000 one-time systems and transition spending, $112,000 buyer transaction costs, and $135,000 working capital. With the $1.88 million consideration, total buyer uses are $2.223 million. These are invented planning figures, not integration benchmarks or a financing approval.

Separate recurring support from one-time migration and avoid overlaps. Identify the staff and vendors responsible, the expected timing, and a downside case with delayed or absent savings. The buyer’s proposed synergies should be tested against available capacity and patient continuity, not accepted solely because its existing organization is larger.

How should the seller’s continuing clinical employment be treated?

Assume the seller proposes to remain for a defined two-year clinical period, with $248,000 annual cash compensation and $20,000 additional employer cost in this teaching case. Together they match the $268,000 replacement-role budget. The terms require their own review; they are not compensation benchmarks.

The annual pay compensates future work and does not increase the $1.88 million price for the existing business. Duties, hours, benefits, professional authority, termination, restrictions, and the effect on any payment obligations need to be explicit in the actual agreements.

Do not assume continued employment removes transition risk. The seller may retain some patient relationships and responsibilities while the buyer changes management and systems. Identify which decisions remain with qualified professionals, which administrative functions change, and who acts if either party wants the employment relationship to end.

What does the closing proceeds model show?

Assume $1.692 million closing cash and a $188,000 seller note. Deduct $144,000 debt, $79,000 transaction expenses, and $56,000 escrow. Immediate cash before taxes is $1.413 million.

With a hypothetical $241,000 planning tax reserve, unreserved immediate cash is $1.172 million. This amount is not an actual tax estimate. The IRS business-sale guidance explains why asset character, allocation, basis, entity structure, and consideration form affect the real result. The CPA needs to model the actual proposal.

The note and escrow have separate rights and timing. The seller’s employment pay is also separate. An offer comparison that adds several years of salary to the price while ignoring the corresponding work can overstate the sale outcome. Keep labor income, closing proceeds, and remaining credit exposure in different parts of the decision.

How should records and service continuity be handled?

Map record custody, authorized access, retention, vendors, scheduling, billing, membership obligations, and patient communication. The HIPAA definitions in 45 CFR 160.103 establish a classification starting point, not permission for every proposed disclosure or system migration. Counsel and technical reviewers should approve the actual process.

Preserve a baseline of patient attendance, provider production, service contribution, complaints through the appropriate channel, and cash. A system change can alter a metric even when the underlying business has not changed. Explain the bridge rather than presenting every difference as successful integration or lost demand.

Use a defined transition checklist and seller role with named owners. The purchaser should be able to operate after the agreed handover without relying on an informal promise that the physician will continue handling every local issue. Professional and administrative responsibility should match the documents and actual staffing.

What is the lesson from a strategic physician sale?

A strategic acquirer can have useful resources, but the seller still needs a clear earnings denominator, complete price structure, and realistic continuing role. The illustration separates standalone value, buyer-specific improvements, future labor income, immediate cash, and deferred exposure.

Use the seller hub, buyer roadmap, valuation hub, and operations guide. The medical director guide addresses continuity and the Four-Number Med Spa Valuation Screen organizes earnings.

Apply the offer-to-proceeds bridge to competing proposals. Replace every teaching input with verified records and qualified advice before using this example’s structure to evaluate a real sale or acquisition.

Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.